Tenon Medical (TNON) Cash & Equivalents (2021 - 2026)

Tenon Medical's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 55.32% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 55.32% YoY), while the FY2025 annual figure was $3.8 million, down 42.52% from the prior year.
• Cash & Equivalents was $4.6 million for Q1 2026 at Tenon Medical, up from $3.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $10.3 million in Q1 2025 to a low of $2.0 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $5.0 million across 5 years, with a median of $4.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents slumped 66.37% in 2024, then soared 298.68% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $2.1 million in 2022, then climbed by 14.04% to $2.4 million in 2023, then jumped by 169.15% to $6.5 million in 2024, then slumped by 42.52% to $3.8 million in 2025, then gained by 22.66% to $4.6 million in 2026.
• The last three Cash & Equivalents figures came in at $4.6 million (Q1 2026), $3.8 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.